Skip to search.
 All Ordinaries Up 0.92%

Synta Pharmaceuticals Corp. (SNTA)

-NasdaqGM
0.19 Down 0.01(3.11%) 11 Feb 08:00
Prev Close:0.20
Open:0.20
Bid:0.11 x 100
Ask:0.59 x 10000
1y Target Est:8.00
Beta:0.774722
Next Earnings Date:N/A
Day's Range:0.17 - 0.20
52wk Range:0.15 - 3.17
Volume:1,029,165
Avg Vol (3m):1,686,680
Market Cap:26.18M
P/E (ttm):N/A
EPS (ttm):-0.65
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
SNTADown 3.11%26.18M
INFIUp 1.25%279.14M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.63
Quarterly EPS Est (Dec-15) :-0.16
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Synta Pharmaceuticals Corp., a biopharmaceutical company, focuses on the research, development, and commercialization of novel oncology medicines for cancer patients. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback